RNA therapeutics for treatment of diabetes

Diabetes is an ongoing global problem as it affects health of more than 537 million people around the world. Diabetes leaves many serious complications that affect patients and can cause death if not detected and treated promptly. Some of the complications of diabetes include impaired vascular system, increased risk of stroke, neurological diseases that cause pain and numbness, diseases related to the retina leading to blindness, and other complications affecting kidneys, heart failure, muscle weakness, muscle atrophy. All complications of diabetes seriously affect the health of patients. Recently, gene therapy has emerged as a viable treatment strategy for various diseases. DNA and RNA are among the target molecules that can change the structure and function of proteins and are effective methods of treating diseases, especially genetically inherited diseases. RNA therapeutics has attracted deep interest as it has been approved for application in the treatment of functional system disorders such as spinal muscular atrophy, and muscular dystrophy. In this review, we cover the types of RNA therapies considered for treatment of diabetes. In particular, we delve into the mechanism of action of RNA therapies for diabetes, and studies involving testing of these RNA therapies. Finally, we have highlighted the limitations of the current understanding in the mechanism of action of RNA therapies.

RNA therapeutics for regenerative medicine

It is estimated that millions of people around the world experience various types of tissue injuries every year. Regenerative medicine was born and developed for understanding and application with the aim of replacing affected organs or some cells. The research, manufacture, production, and distribution of RNA in cells have acted as a basic foundation for the development and testing of therapies and treatments that are widely applied in different fields of medicine. Vaccines against COVID-19 are considered one of the brilliant and outstanding successes of RNA therapeutics research. With the characteristics of bio-derived RNA therapeutics, the mechanism of rapid implementation, safe production, and flexibility to create proteins depending on actual requirements. Based on the advantages above in this review, we discuss RNA therapeutics for regenerative medicine, and the types of RNA therapies currently being used for regenerative medicine. The relationship between disease and regenerative medicine is currently being studied or tested in RNA therapeutics. We have also covered the mechanisms of action of RNA therapy for regenerative medicine and some of the limitations in our current understanding of the effects of RNA therapy in this area. Additionally, we have also covered developing RNA therapeutics for regenerative medicine, focusing on RNA therapeutics for regenerative medicine. As a final point, we discuss potential applications for therapeutics for regenerative medicine in the future, as well as their mechanisms.

Residual toxins on aquatic animals in the Pacific areas: Current findings and potential health effects

The Pacific Ocean is among the five largest and deepest oceans in the world. The area of the Pacific Ocean covers about 28 % of the Earth's surface. This is the habitat of many marine species, and its diversity is recognized as a fundamental element of Pacific culture and heritage. The ecosystems of aquatic animals are highly affected by climate change and by other factors. Residual toxins on aquatic animals can be categorized into two types based on origin: toxins of marine origin and toxins associated with human activity. Residual toxins have emerged as a global concern in recent years due to their frequent presence in aquatic environments. Furthermore, residual toxins in organisms living in the marine environment in the Pacific Ocean region also seriously affect food safety, food security, and especially human health. In this review we discuss important issues about residual toxins on aquatic animals in the Pacific areas specifically about the types of toxins that exist in marine animals, their contamination pathways in the Asia, Pacific region and the potential health effects for humans, the application of information technology and artificial intelligence in residual toxins on aquatic animal.